| - GRCh37:
- Chr10:4646926-47531169
- GRCh38:
- Chr10:4604734-48074662
| ABI1, ACBD5, ACBD7, ACBD7-DCLRE1CP1, AGAP10, AGAP4, AGAP9, AKR1C1, AKR1C2, AKR1C3, AKR1C4, AKR1C8, AKR1E2, ALOX5, ANKRD16, ANKRD26, ANKRD30A, ANTXRL, ANXA8, ANXA8L1, APBB1IP, ARHGAP12, ARHGAP21, ARL5B, ARMC3, ASB13, ATP5F1C, BAMBI, BEND7, BEND7-DT, BMI1, BMS1, C10orf113, C10orf126, C10orf67, C10orf67-AS1, C1QL3, CACNB2, CALML3, CALML3-AS1, CALML5, CAMK1D, CCDC3, CCDC7, CCNY, CDC123, CDNF, CELF2, CELF2-AS1, CELF2-AS2, CELF2-DT, COMMD3, COMMD3-BMI1, CREM, CSGALNACT2, CSGALNACT2-DT, CUBN, CUL2, CXCL12, DCLRE1C, DEPP1, DHTKD1, DNAJC1, EBLN1, ECHDC3, ENKUR, EPC1, EPC1-AS1, FAM107B, FAM171A1, FAM238A, FAM238B, FAM238C, FAM245B, FAM25C, FAM25E, FAM25G, FBH1, FRMD4A, FXYD4, FZD8, GAD2, GATA3, GATA3-AS1, GDF10, GDF2, GDI2, GJD4, GPR158, GPR158-AS1, GPRIN2, HACD1, HNRNPF, HSPA14, IATPR, IL15RA, IL2RA, ITGA8, ITGB1, ITGB1-DT, ITIH2, ITIH5, JCAD, KIAA1217, KIF5B, KIN, LASTR, LINC00619, LINC00705, LINC00706, LINC00707, LINC00708, LINC00709, LINC00710, LINC00836, LINC00837, LINC00838, LINC00839, LINC00840, LINC00841, LINC00842, LINC00993, LINC00999, LINC01264, LINC01516, LINC01517, LINC01518, LINC02561, LINC02623, LINC02628, LINC02629, LINC02630, LINC02632, LINC02634, LINC02637, LINC02642, LINC02643, LINC02644, LINC02648, LINC02649, LINC02652, LINC02654, LINC02656, LINC02658, LINC02659, LINC02664, LINC02665, LINC02670, LINC02673, LINC02676, LINC02677, LINC02678, LINC02881, LINC02916, LINC03027, LINC03028, LINC03029, LINP1, LOC100130992, LOC100505502, LOC101928051, LOC101928272, LOC101928453, LOC101928834, LOC101929073, LOC101929279, LOC101929431, LOC102724323, LOC102724593, LOC105376384, LOC105376387, LOC105376390, LOC105376398, LOC105376420, LOC105378269, LOC105378289, LOC105378577, LOC106736614, LOC106783505, LOC106783576, LOC107001062, LOC107275222, LOC107275223, LOC107275226, LOC108004524, LOC108353817, LOC108353819, LOC108903148, LOC108903149, LOC110121348, LOC110121355, LOC110121399, LOC110121405, LOC110121406, LOC110121476, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111464994, LOC111501766, LOC111589212, LOC111818964, LOC111818965, LOC111818966, LOC111818967, LOC111946222, LOC111946223, LOC111946224, LOC111946225, LOC111946226, LOC111946227, LOC111946228, LOC111946229, LOC111946230, LOC111946231, LOC111946232, LOC111946234, LOC111946236, LOC111946237, LOC111946238, LOC111946239, LOC111946241, LOC111946242, LOC111946244, LOC111946245, LOC111946246, LOC111946251, LOC111946252, LOC114827857, LOC116216107, LOC116216108, LOC116216109, LOC116216110, LOC116216111, LOC116216112, LOC121366038, LOC121366039, LOC121366040, LOC121366041, LOC121366042, LOC121366043, LOC121366044, LOC121366045, LOC121366046, LOC121366047, LOC121366048, LOC121366049, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121811723, LOC121811724, LOC121811725, LOC121811726, LOC121811727, LOC121811728, LOC121811729, LOC121811730, LOC124403905, LOC124403906, LOC124403907, LOC124403908, LOC124403909, LOC124403910, LOC124403911, LOC124403912, LOC124403913, LOC124403914, LOC124403915, LOC124403916, LOC124403917, LOC124403918, LOC124403919, LOC124403920, LOC124403921, LOC124403922, LOC124403923, LOC124403924, LOC124403925, LOC124403926, LOC124403927, LOC124403928, LOC124403929, LOC124403930, LOC124403931, LOC124403932, LOC124403933, LOC124403934, LOC124403935, LOC124403936, LOC124403937, LOC124403938, LOC124403939, LOC124403940, LOC124403941, LOC124403942, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC126860845, LOC126860846, LOC126860847, LOC126860848, LOC126860849, LOC126860850, LOC126860851, LOC126860852, LOC126860853, LOC126860854, LOC126860855, LOC126860856, LOC126860857, LOC126860858, LOC126860859, LOC126860860, LOC126860861, LOC126860862, LOC126860863, LOC126860864, LOC126860865, LOC126860866, LOC126860867, LOC126860868, LOC126860869, LOC126860870, LOC126860871, LOC126860872, LOC126860873, LOC126860874, LOC126860875, LOC126860876, LOC126860877, LOC126860878, LOC126860879, LOC126860880, LOC126860881, LOC126860882, LOC126860883, LOC126860884, LOC126860885, LOC126860886, LOC126860887, LOC126860888, LOC126860889, LOC126860890, LOC126860891, LOC126860892, LOC126860893, LOC126860894, LOC126860895, LOC126860896, LOC126860897, LOC126860898, LOC126860899, LOC126860900, LOC126860901, LOC126860902, LOC126860903, LOC126860904, LOC126860905, LOC126860906, LOC126860907, LOC126860908, LOC126860909, LOC126860910, LOC126860911, LOC126860912, LOC126860913, LOC126860914, LOC126860915, LOC126860916, LOC126860917, LOC126860918, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC128462383, LOC128462384, LOC128462385, LOC128462386, LOC128462408, LOC283028, LYZL1, LYZL2, MACORIS, MALRD1, MANCR, MAP3K8, MARCHF8, MASTL, MCM10, MCS+9.7, MEIG1, MINDY3, MIR1265, MIR1915, MIR1915HG, MIR3155A, MIR3155B, MIR3156-1, MIR3611, MIR4293, MIR4480, MIR4481, MIR4675, MIR4683, MIR5100, MIR511, MIR548AK, MIR548Q, MIR603, MIR604, MIR7162, MIR8086, MIR938, MKX, MKX-AS1, MLLT10, MPP7, MRC1, MSANTD7, MSMB, MSRB2, MTPAP, MTRNR2L7, MYO3A, NCOA4, NEBL, NEBL-AS1, NET1, NMT2, NPY4R, NPY4R2, NRP1, NSUN6, NUDT5, ODAD2, OLAH, OPTN, OR13A1, OTUD1, PARD3, PARD3-DT, PCAT5, PDSS1, PFKFB3, PHYH, PIP4K2A, PLXDC2, PRINS, PRKCQ, PRKCQ-AS1, PROSER2, PROSER2-AS1, PRPF18, PRTFDC1, PTCHD3, PTER, PTF1A, PTPN20, RAB18, RASGEF1A, RASSF4, RBM17, RBP3, RET, RPP38, RPP38-DT, RSU1, SEC61A2, SEPHS1, SFMBT2, SKIDA1, SLC39A12, SLC39A12-AS1, SNORA74C-1, SNORA86, SNORD129, SNORD130, SNORD3J, SPAG6, ST8SIA6, ST8SIA6-AS1, STAM, STAM-DT, SUV39H2, SUV39H2-DT, SVIL, SVIL-AS1, SYT15, SYT15-AS1, SYT15B, TAF3, TASOR2, THNSL1, TIMM23, TMEM236, TMEM72, TMEM72-AS1, TRDMT1, TRN-GTT2-3, TRV-TAC3-1, TUBAL3, UCMA, UCN3, UPF2, USP6NL, USP6NL-AS1, VIM, VIM-AS1, WAC, WAC-AS1, WASHC2C, YME1L1, ZEB1, ZEB1-AS1, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF248, ZNF25, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33A, ZNF33B, ZNF37A, ZNF438, ZNF485, ZNF487, ZNF488 | | See cases | Benign (Feb 4, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr10:42607635-69160433
- GRCh38:
- Chr10:42112187-67400675
| LOC121366055, LOC121366056, LOC121366057, LOC121811730, LOC121815939, LOC121815940, LOC121815941, LOC121815942, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC124403958, LOC124403959, LOC124403960, LOC124403961, LOC124403962, LOC124403963, LOC124403966, LOC124403967, LOC124403968, LOC124403969, LOC124403970, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC126860934, LOC126860935, LOC126860936, LOC126860937, LOC126860938, LOC126860939, LOC126860940, LOC126860941, LOC126860942, LOC126860943, LOC126860944, LOC126860945, LOC126860946, LOC126860947, LOC126860948, LOC283028, LOC283045, LRRC18, LRRTM3, MAPK8, MARCHF8, MBL2, MCS+9.7, MIR1296, MIR3156-1, MIR3924, MIR4294, MIR5100, MIR548F1, MIR605, MRLN, MSMB, MTRNR2L5, NCOA4, NPY4R, NPY4R2, NRBF2, OGDHL, OR13A1, PARG, PCDH15, PGBD3, PHYHIPL, PRKG1, PRKG1-AS1, PTPN20, RASGEF1A, RASSF4, RBP3, REEP3, RET, RHOBTB1, RTKN2, SGMS1, SGMS1-AS1, SLC16A9, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TFAM, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM26, TMEM26-AS1, TMEM273, TMEM72, TMEM72-AS1, UBE2D1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33B, ZNF365, ZNF485, ZNF487, ZNF488, ZWINT, A1CF, ADO, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANK3, ANK3-DT, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ARID5B, ASAH2, ASAH2B, BICC1, BMS1, C10orf53, C10orf71, C10orf71-AS1, CABCOCO1, CCDC6, CCEPR, CDK1, CHAT, CISD1, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CTNNA3, CXCL12, DEPP1, DKK1, DRGX, EGR2, ERCC6, FAM13C, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, IPMK, JMJD1C, JMJD1C-AS1, JMJD1C-AS2, LINC00619, LINC00839, LINC00840, LINC00841, LINC00842, LINC00844, LINC00845, LINC01264, LINC01515, LINC01518, LINC01553, LINC02621, LINC02623, LINC02632, LINC02637, LINC02658, LINC02659, LINC02671, LINC02672, LINC02881, LINC02916, LINC03029, LNCAROD, LOC101928961, LOC102724323, LOC102724593, LOC102724719, LOC105378269, LOC105378289, LOC105378305, LOC105378311, LOC105378328, LOC105378577, LOC106736614, LOC107001062, LOC107984236, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC111946247, LOC111946248, LOC111946249, LOC112268068, LOC113939916, LOC114827857, LOC116216113, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054 | | See cases | Pathogenic (Aug 20, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr10:42890649-52636819
- GRCh38:
- Chr10:42395201-50877059
| A1CF, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ASAH2, ASAH2B, BMS1, C10orf53, C10orf71, C10orf71-AS1, CHAT, CSGALNACT2, CSGALNACT2-DT, CXCL12, DEPP1, DRGX, ERCC6, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, LINC00619, LINC00839, LINC00840, LINC00841, LINC00842, LINC01264, LINC01518, LINC02623, LINC02632, LINC02637, LINC02658, LINC02659, LINC02881, LINC02916, LINC03029, LOC102724323, LOC102724593, LOC105378269, LOC105378289, LOC105378577, LOC106736614, LOC107001062, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC113939916, LOC114827857, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121811730, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC283028, LRRC18, MAPK8, MARCHF8, MCS+9.7, MIR3156-1, MIR4294, MIR5100, MSMB, NCOA4, NPY4R, NPY4R2, OGDHL, OR13A1, PARG, PGBD3, PTPN20, RASGEF1A, RASSF4, RBP3, RET, SGMS1, SGMS1-AS1, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM273, TMEM72, TMEM72-AS1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33B, ZNF485, ZNF487, ZNF488 | | See cases | Pathogenic (Sep 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr10:42890664-43729688
- GRCh38:
- Chr10:42395216-43234240
| BMS1, CSGALNACT2, CSGALNACT2-DT, LINC00839, LINC01264, LINC01518, LINC02623, LINC02632, LOC105378269, LOC106736614, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111946237, LOC124403943, LOC124403944, LOC126860919, LOC283028, MCS+9.7, MIR5100, RASGEF1A, RET, ZNF33B | | See cases | Uncertain significance (Dec 22, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr10:43180754-75475666
- GRCh38:
- Chr10:42685306-73715908
| SLC18A3, SLC25A16, SLC29A3, SNORA11F, SNORA74C-1, SNORA74C-2, SNORD3J, SNORD98, SPOCK2, SRGN, STOX1, SUPV3L1, SYNPO2L, SYNPO2L-AS1, SYT15, SYT15-AS1, SYT15B, TACR2, TBATA, TET1, TFAM, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM26, TMEM26-AS1, TMEM273, TMEM72, TMEM72-AS1, TRS-TGA1-1, TSPAN15, TYSND1, UBE2D1, UNC5B, UNC5B-AS1, USP54, VPS26A, VSIR, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF365, ZNF485, ZNF487, ZNF488, ZWINT, A1CF, ADAMTS14, ADO, AGAP10, AGAP4, AGAP5, AGAP6, AGAP9, AIFM2, ALOX5, ANAPC16, ANK3, ANK3-DT, ANTXRL, ANXA7, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ARID5B, ASAH2, ASAH2B, ASCC1, ATOH7, BICC1, BMS1, C10orf105, C10orf53, C10orf71, C10orf71-AS1, CABCOCO1, CCAR1, CCDC6, CCEPR, CDH23, CDH23-AS1, CDK1, CFAP70, CHAT, CHST3, CISD1, COL13A1, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CTNNA3, CXCL12, DDIT4, DDX21, DDX50, DEPP1, DKK1, DNA2, DNAJB12, DNAJC12, DNAJC9, DNAJC9-AS1, DRGX, ECD, EGR2, EIF4EBP2, ERCC6, FAM13C, FAM149B1, FAM170B, FAM170B-AS1, FAM241B, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HERC4, HK1, HKDC1, HNRNPF, HNRNPH3, IPMK, JMJD1C, JMJD1C-AS1, JMJD1C-AS2, KIFBP, LINC00619, LINC00840, LINC00841, LINC00842, LINC00844, LINC00845, LINC01264, LINC01515, LINC01518, LINC01553, LINC02621, LINC02622, LINC02623, LINC02632, LINC02636, LINC02637, LINC02651, LINC02658, LINC02659, LINC02671, LINC02672, LINC02881, LINC02916, LINC03029, LNCAROD, LOC101928961, LOC101928994, LOC102724323, LOC102724593, LOC102724719, LOC105378269, LOC105378289, LOC105378305, LOC105378311, LOC105378328, LOC105378577, LOC106736614, LOC107001062, LOC107832851, LOC107984236, LOC108178982, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111365158, LOC111365196, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC111946247, LOC111946248, LOC111946249, LOC111946250, LOC111949323, LOC111982863, LOC111982864, LOC111982865, LOC111982866, LOC111982867, LOC111982868, LOC111982869, LOC111982870, LOC112268068, LOC113939916, LOC114827857, LOC116216113, LOC116216114, LOC120807611, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121366056, LOC121366057, LOC121366058, LOC121366059, LOC121366060, LOC121366061, LOC121366062, LOC121811730, LOC121815939, LOC121815940, LOC121815941, LOC121815942, LOC121815943, LOC121815944, LOC121815945, LOC121815946, LOC121815947, LOC121815948, LOC121815949, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC124403958, LOC124403959, LOC124403960, LOC124403961, LOC124403962, LOC124403963, LOC124403966, LOC124403967, LOC124403968, LOC124403969, LOC124403970, LOC124403971, LOC124403972, LOC124403973, LOC124403974, LOC124403975, LOC124403976, LOC124416833, LOC124416834, LOC124416835, LOC124416836, LOC124416837, LOC124416838, LOC124416839, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC126860934, LOC126860935, LOC126860936, LOC126860937, LOC126860938, LOC126860939, LOC126860940, LOC126860941, LOC126860942, LOC126860943, LOC126860944, LOC126860945, LOC126860946, LOC126860947, LOC126860948, LOC126860949, LOC126860950, LOC126860951, LOC126860952, LOC126860953, LOC126860954, LOC126860955, LOC283028, LOC283045, LRRC18, LRRC20, LRRTM3, MACROH2A2, MAPK8, MARCHF8, MBL2, MCS+9.7, MCU, MICU1, MIR1296, MIR3156-1, MIR3924, MIR4294, MIR4676, MIR5100, MIR548F1, MIR605, MIR7151, MIR7152, MRLN, MRPS16, MSMB, MSS51, MTRNR2L5, MYOZ1, MYPN, NCOA4, NEUROG3, NODAL, NPFFR1, NPY4R, NPY4R2, NRBF2, NUDT13, OGDHL, OIT3, OR13A1, P4HA1, PALD1, PARG, PBLD, PCBD1, PCDH15, PGBD3, PHYHIPL, PLA2G12B, PPA1, PPP3CB, PPP3CB-AS1, PRF1, PRKG1, PRKG1-AS1, PSAP, PTPN20, RASGEF1A, RASSF4, RBP3, REEP3, RET, RHOBTB1, RTKN2, RUFY2, SAR1A, SGMS1, SGMS1-AS1, SGPL1, SIRT1, SLC16A9 | | See cases | Pathogenic (Sep 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr10:43379742-54025077
- GRCh38:
- Chr10:42884294-52265317
| A1CF, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ASAH2, ASAH2B, C10orf53, C10orf71, C10orf71-AS1, CHAT, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CXCL12, DEPP1, DRGX, ERCC6, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, LINC00619, LINC00840, LINC00841, LINC00842, LINC01264, LINC02637, LINC02658, LINC02659, LINC02881, LINC02916, LINC03029, LOC102724323, LOC102724593, LOC102724719, LOC105378289, LOC105378577, LOC106736614, LOC107001062, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC113939916, LOC114827857, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121811730, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LRRC18, MAPK8, MARCHF8, MCS+9.7, MIR3156-1, MIR4294, MIR5100, MIR605, MSMB, NCOA4, NPY4R, NPY4R2, OGDHL, OR13A1, PARG, PGBD3, PRKG1, PTPN20, RASGEF1A, RASSF4, RBP3, RET, SGMS1, SGMS1-AS1, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM273, TMEM72, TMEM72-AS1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF485, ZNF487, ZNF488 | | See cases | Pathogenic (Nov 30, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr10:43572180
- GRCh38:
- Chr10:43076732
| LOC106736614, RET | | not provided | Likely benign (Feb 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572296
- GRCh38:
- Chr10:43076848
| LOC106736614, RET | | not provided | Benign (May 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572426
- GRCh38:
- Chr10:43076978
| LOC106736614, RET | | not provided | Likely benign (Apr 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572458-43572459
- GRCh38:
- Chr10:43077010-43077011
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2a | Uncertain significance (Aug 18, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572481
- GRCh38:
- Chr10:43077033
| LOC106736614, RET | | not provided | Likely benign (Jun 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572507
- GRCh38:
- Chr10:43077059
| LOC106736614, RET | | Hirschsprung Disease, Dominant, Renal hypodysplasia/aplasia 1, Pheochromocytoma, Multiple endocrine neoplasia, not provided | Benign (Jun 24, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572511
- GRCh38:
- Chr10:43077063
| LOC106736614, RET | | not provided, Hirschsprung Disease, Dominant, Multiple endocrine neoplasia, Renal hypodysplasia/aplasia 1, Pheochromocytoma | Benign/Likely benign (Jun 15, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572520
- GRCh38:
- Chr10:43077072
| LOC106736614, RET | | Multiple endocrine neoplasia, Hirschsprung Disease, Dominant, Pheochromocytoma, Renal hypodysplasia/aplasia 1 | Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572534
- GRCh38:
- Chr10:43077086
| LOC106736614, RET | | Pheochromocytoma, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572547
- GRCh38:
- Chr10:43077099
| LOC106736614, RET | | Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma, Multiple endocrine neoplasia | Benign/Likely benign (Jul 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572549
- GRCh38:
- Chr10:43077101
| LOC106736614, RET | | Multiple endocrine neoplasia, Pheochromocytoma, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572575
- GRCh38:
- Chr10:43077127
| LOC106736614, RET | | Multiple endocrine neoplasia, Pheochromocytoma, Hereditary cancer-predisposing syndrome, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1 | Conflicting interpretations of pathogenicity (Jun 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572639
- GRCh38:
- Chr10:43077191
| LOC106736614, RET | | not provided | Benign (Mar 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572656
- GRCh38:
- Chr10:43077208
| LOC106736614, RET | | Hirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma, Multiple endocrine neoplasia | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572670
- GRCh38:
- Chr10:43077222
| RET, LOC106736614 | | not provided, Multiple endocrine neoplasia, type 2 | Conflicting interpretations of pathogenicity (Feb 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572697-43623727
- GRCh38:
- Chr10:43077249-43128279
| LOC106736614, LOC110121502, MCS+9.7, RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572700-43572703
- GRCh38:
- Chr10:43077252-43077255
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572701
- GRCh38:
- Chr10:43077253
| LOC106736614, RET | | not provided | Uncertain significance (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572701-43623723
- GRCh38:
- Chr10:43077253-43128275
| LOC106736614, LOC110121502, MCS+9.7, RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Mar 7, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572702-43572703
- GRCh38:
- Chr10:43077254-43077255
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Jan 5, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572702
- GRCh38:
- Chr10:43077254
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 2, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572703
- GRCh38:
- Chr10:43077255
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572704
- GRCh38:
- Chr10:43077256
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Dec 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572705
- GRCh38:
- Chr10:43077257
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome, not provided, Pheochromocytoma, Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b, Familial medullary thyroid carcinoma, not specified | Conflicting interpretations of pathogenicity (May 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572706
- GRCh38:
- Chr10:43077258
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Jan 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572708-43572709
- GRCh38:
- Chr10:43077260-43077261
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, not specified
| Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572712
- GRCh38:
- Chr10:43077264
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Likely benign (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572713
- GRCh38:
- Chr10:43077265
| LOC106736614, RET | K3E | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572716
- GRCh38:
- Chr10:43077268
| LOC106736614, RET | A4T | Multiple endocrine neoplasia, type 2 | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572717
- GRCh38:
- Chr10:43077269
| LOC106736614, RET | A4V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572719
- GRCh38:
- Chr10:43077271
| RET, LOC106736614 | T5A | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572720
- GRCh38:
- Chr10:43077272
| LOC106736614, RET | T5M | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572720
- GRCh38:
- Chr10:43077272
| LOC106736614, RET | T5R | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572721
- GRCh38:
- Chr10:43077273
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2 | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572721
- GRCh38:
- Chr10:43077273
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572721
- GRCh38:
- Chr10:43077273
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Likely benign (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572722
- GRCh38:
- Chr10:43077274
| LOC106736614, RET | S6P | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572722
- GRCh38:
- Chr10:43077274
| LOC106736614, RET | S6A | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572724
- GRCh38:
- Chr10:43077276
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572724
- GRCh38:
- Chr10:43077276
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Dec 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572724
- GRCh38:
- Chr10:43077276
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2, not provided, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Sep 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572725
- GRCh38:
- Chr10:43077277
| LOC106736614, RET | G7S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572726
- GRCh38:
- Chr10:43077278
| LOC106736614, RET | G7V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572726
- GRCh38:
- Chr10:43077278
| LOC106736614, RET | G7D | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, not provided, Multiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2a, Pheochromocytoma, Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1 | Uncertain significance (Sep 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572727
- GRCh38:
- Chr10:43077279
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (May 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572728
- GRCh38:
- Chr10:43077280
| LOC106736614, RET | A8S | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Mar 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572729
- GRCh38:
- Chr10:43077281
| LOC106736614, RET | A8V | Hereditary cancer-predisposing syndrome | Uncertain significance (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572730
- GRCh38:
- Chr10:43077282
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Dec 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572733
- GRCh38:
- Chr10:43077285
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (Oct 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572733
- GRCh38:
- Chr10:43077285
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome | Likely benign (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572735
- GRCh38:
- Chr10:43077287
| LOC106736614, RET | G10A | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572735-43572736
- GRCh38:
- Chr10:43077287-43077288
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572735-43572736
- GRCh38:
- Chr10:43077287-43077288
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572735
- GRCh38:
- Chr10:43077287
| LOC106736614, RET | G10E | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572735
- GRCh38:
- Chr10:43077287
| LOC106736614, RET | G10V | Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572736
- GRCh38:
- Chr10:43077288
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572736
- GRCh38:
- Chr10:43077288
| LOC106736614, RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Likely benign (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572737
- GRCh38:
- Chr10:43077289
| LOC106736614, RET | L11M | Hereditary cancer-predisposing syndrome, not specified, Multiple endocrine neoplasia, type 2
| Conflicting interpretations of pathogenicity (Sep 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572737
- GRCh38:
- Chr10:43077289
| LOC106736614, RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2b, Pheochromocytoma, Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2 | Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572737
- GRCh38:
- Chr10:43077289
| LOC106736614, RET | L11V | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572740
- GRCh38:
- Chr10:43077292
| RET | R12G | Multiple endocrine neoplasia, type 2 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572741
- GRCh38:
- Chr10:43077293
| RET | R12H | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572742-43572743
- GRCh38:
- Chr10:43077294-43077295
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Sep 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572743-43572744
- GRCh38:
- Chr10:43077295-43077296
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572743-43572751
- GRCh38:
- Chr10:43077295-43077303
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Sep 25, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572745
- GRCh38:
- Chr10:43077297
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572745
- GRCh38:
- Chr10:43077297
| RET | | Hereditary cancer-predisposing syndrome | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572747-43572749
- GRCh38:
- Chr10:43077299-43077301
| RET | | Hereditary cancer-predisposing syndrome | Uncertain significance (Oct 29, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572747
- GRCh38:
- Chr10:43077299
| RET | L14P | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572749-43572750
- GRCh38:
- Chr10:43077301-43077302
| RET | | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572749-43572750
- GRCh38:
- Chr10:43077301-43077302
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Conflicting interpretations of pathogenicity (Dec 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572749
- GRCh38:
- Chr10:43077301
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Likely benign (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572749-43572750
- GRCh38:
- Chr10:43077301-43077302
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Conflicting interpretations of pathogenicity (Jun 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572749-43572750
- GRCh38:
- Chr10:43077301-43077302
| RET | | not provided, not specified, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a | Conflicting interpretations of pathogenicity (Feb 27, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572750-43572758
- GRCh38:
- Chr10:43077302-43077310
| RET | | Hereditary cancer-predisposing syndrome | Likely benign (Dec 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572750-43572751
- GRCh38:
- Chr10:43077302-43077303
| RET | L16fs | Hereditary cancer-predisposing syndrome | Pathogenic (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572750
- GRCh38:
- Chr10:43077302
| RET | L15S | Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572750-43572755
- GRCh38:
- Chr10:43077302-43077307
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572762-43572764
- GRCh38:
- Chr10:43077302-43077304
| RET | L19del | Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2a, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Jan 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr10:43572751
- GRCh38:
- Chr10:43077303
| RET | | not provided, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2
| Likely benign (Sep 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572752
- GRCh38:
- Chr10:43077304
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Likely benign (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572753
- GRCh38:
- Chr10:43077305
| RET | L16Q | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572754
- GRCh38:
- Chr10:43077306
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome | Likely benign (Mar 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572755
- GRCh38:
- Chr10:43077307
| RET | L17M | Hereditary cancer-predisposing syndrome | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572755
- GRCh38:
- Chr10:43077307
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Likely benign (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572756
- GRCh38:
- Chr10:43077308
| RET | L17P | Multiple endocrine neoplasia, type 2, Breast carcinoma, Family history of cancer
| Uncertain significance (Jan 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572756-43572757
- GRCh38:
- Chr10:43077308-43077309
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Apr 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572757
- GRCh38:
- Chr10:43077309
| RET | | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Likely benign (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572758
- GRCh38:
- Chr10:43077310
| RET | | Multiple endocrine neoplasia, type 2 | Likely benign (Jun 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572759
- GRCh38:
- Chr10:43077311
| RET | L18P | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Aug 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572760
- GRCh38:
- Chr10:43077312
| RET | | Hereditary cancer-predisposing syndrome | Likely benign (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572761
- GRCh38:
- Chr10:43077313
| RET | L19M | Hereditary cancer-predisposing syndrome | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr10:43572762
- GRCh38:
- Chr10:43077314
| RET | L19P | Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2 | Uncertain significance (Dec 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr10:43572762-43572763
- GRCh38:
- Chr10:43077314-43077315
| RET | | Multiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Oct 18, 2022) | criteria provided, multiple submitters, no conflicts |